Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on EBR Systems.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise as Proteomics inks Sonic deal
Health & Biotech
ScoPo’s (he’s back) Powerplays: ASX health stocks fall, Volpara ‘elephants’ strategy pays off
Health & Biotech
ScoPo’s (actually still Iain’s) Powerplays: ASX health sector falls, but several stocks on upward run
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise, ImpediMed surges 99% on NCCN guidelines update
News
After Neuren’s success, which other ASX health stocks are knocking on the US FDA door?
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but keep watchful eye on upcoming catalysts
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise, Mach 7 lands largest contract and posts record quarter
Health & Biotech
ScoPo’s Powerplays: Is it time to fill the Christmas stocking early with some ASX health stocks?
Health & Biotech
ASX Health Stocks: Canada says yes to Telix, while EBR keeps market in suspense over pending announcement
News
Closing Bell: iSelect jumps 75%; Asian markets choke ahead of most important US CPI data since forever
News
Closing Bell: ASX falters after a promising start
News
ASX Small Caps Lunch Wrap: Who else is laughing at someone else’s expense today?
News
Market Highlights: Wall Street’s worst start in 50 years and 5 ASX small caps to watch on Friday
Experts
ScoPo’s Powerplays: ASX health stocks offer bargains galore during tax time sell down
Experts
ScoPo’s Powerplays: Health stocks on a wave of jitters as inflation storm gathers
Health & Biotech
Check Up: Gloomy days for biotechs, but there were significant moves on the ASX this week
Health & Biotech
